Comprehensive Genomic Profiling in the Community Setting: Perspective from a Pathologist and an Oncologist

Carlo Bifulco, MD
PChief Medical Officer
Providence Genomics
Member and Director,Translational Molecular Pathology and Molecular Genomics
Earle A. Chiles Research Institute

Dr. Carlo Bifulco is a Surgical Pathologist with additional fellowship subspecialty training, expertise, and board certification in Molecular Genetic Pathology and Hematopathology. Dr. Bifulco currently serves as Chief Medical Officer, Providence Genomics, and as Member and Director of Translational Molecular Pathology and Molecular Genomics at the Earle A. Chiles Research Institute in Portland, Oregon, a division of Providence Cancer Institute. He oversees Providence Molecular Genomics Laboratory, one of the largest clinical genomics labs in the Pacific Northwest, which provides state-of-the-art genomic sequencing to cancer patients across the seven-state PSJH system.

Prior to joining Providence, Dr. Bifulco served on the Pathology faculty at Yale University and completed fellowships in Oncologic Surgical Pathology and Molecular Genetic Pathology at Memorial Sloan Kettering Cancer Center. His current translational research is focused on supporting the characterization of the tumor immune microenvironment through immunohistochemical and image analysis techniques, and on the integration of genomics with immunotherapies.

Rachel E. Sanborn, MD
Medical Director
Thoracic Oncology Program and Phase I Clinical Trials Program
Earle A. Chiles Research Institute

Dr. Rachel Sanborn is a Full Member of the Earle A. Chiles Research Institute at the Providence Cancer Institute in Portland, Oregon. She is the Medical Director of the Thoracic Oncology Program and Medical Director of the Phase I Clinical Trials Program. She leads a robust portfolio of clinical trials that include cutting-edge research in targeted therapies, novel treatment approaches, and early-stage and combination immunotherapeutics for lung cancer, other thoracic malignancies, and other cancers. She is a member of the Providence Institutional Review Board, the American Lung Association Medical Advisory Workgroup, as well as the Southwest Oncology Group Lung Cancer Working Group and Community Engagement Committee. She has served as co-chair of the Hoosier Cancer Research Network Thoracic Clinical Trials Working Group and is a member of the American Society of Clinical Oncology as well as the International Association for the Study of Lung Cancer.